ID   HPE-Ret-3
AC   CVCL_WT66
SY   Ret-3
DR   Wikidata; Q94217208
RX   DOI=10.1159/000415060;
RX   PubMed=2140233;
RX   PubMed=7550995;
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from 'reticulum cell sarcoma'.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
RX   DOI=10.1159/000415060;
RA   Morikawa S., Harada T., Katoh T.;
RT   "Heterogeneity of cellular origins in human malignant lymphoma cell
RT   line derived from histo-monocytic lineage cells.";
RL   (In book chapter) Cellular, molecular, genetic approaches to immunodiagnosis and immunotherapy. 8th International conference on labeled antibodies, Tokyo, November 1985; Kano K., Mori S., Sugisaki T., Torisu M. (eds.); pp.373-380; Karger; Basel; Switzerland (1988).
//
RX   PubMed=2140233; DOI=10.1111/j.1440-1827.1990.tb01549.x;
RA   Nakano A., Harada T., Morikawa S., Kato Y.;
RT   "Expression of leukocyte common antigen (CD45) on various human
RT   leukemia/lymphoma cell lines.";
RL   Acta Pathol. Jpn. 40:107-115(1990).
//
RX   PubMed=7550995; DOI=10.1111/j.1440-1827.1995.tb03455.x;
RA   Nagasaki M., Harada T., Morikawa S.;
RT   "A new monoclonal antibody (IE8) reactive with dendritically shaped
RT   cells in the human tonsil.";
RL   Pathol. Int. 45:266-274(1995).
//